Menlo Park, CA, United States of America

Michael D Laufer

USPTO Granted Patents = 171 

 

 

Average Co-Inventor Count = 2.4

ph-index = 64

Forward Citations = 27,071(Granted Patents)


Inventors with similar research interests:


Company Filing History:

goldMedal31 out of 48 
 
Asthmatx, Inc.
 patents
silverMedal14 out of 29 
 
Avails Medical, Inc.
 patents
bronzeMedal12 out of 37 
 
Vnus Medical Technologies, Inc.
 patents
411 out of 2,207 
 
Ethicon Endo-surgery, Inc.
 patents
511 out of 28 
 
Broncus Technologies, Inc.
 patents
69 out of 48 
 
Broncus Medical Inc.
 patents
78 out of 9 
 
Hearten Medical
 patents
88 out of 6,260 
 
Boston Scientific Scimed, Inc.
 patents
97 out of 7 
 
Ndo Surgical. Inc.
 patents
104 out of 1,159 
 
Tyco Healthcare Group LP
 patents
114 out of 4 
 
Cordynamix, Inc.
 patents
123 out of 23 
 
Surx, Inc.
 patents
133 out of 3 
 
Ntero Surgical, Inc.
 patents
142 out of 11 
 
Solarant Medical, Inc.
 patents
152 out of 331 
 
Ams Research Corporation
 patents
162 out of 3 
 
Shi Zi Technology, Ltd.
 patents
172 out of 3 
 
Bee Sight Limited
 patents
182 out of 2 
 
Lenr, Inc.
 patents
191 out of 1 
 
Lenr Solutions, Inc.
 patent
201 out of 1 
 
Ndo Surical, Inc.
 patent
211 out of 1 
 
Co-repair, Inc.
 patent
2232 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Resuscitation Systems
Infectious Agent Detection
Antimicrobial Susceptibility Testing
Diastolic Assist Devices
Fluid Transfer Devices
Airway Treatment Methods
Tissue Excision Techniques
Gastrointestinal Implants
Electrolyte-Insulator-Semiconductor Sensors
Medical Device Tracking
Ablation Methods
Antibiotic Resistance Detection
171 patents (USPTO):Explore Patents

Title: Michael D Laufer: Innovating Medical Devices for Better Healthcare

Introduction:

In the realm of medical device innovation, one name stands out - Michael D Laufer. Based in Menlo Park, CA, Michael has made significant contributions to the field through his numerous patents and groundbreaking inventions. With a keen focus on fluid control devices for medical use and resuscitation methods, Laufer's work has the potential to revolutionize healthcare procedures.

Latest Patents:

Michael D Laufer's latest patents center around medical devices and methods for fluid transfer. These patents describe fluid flow control devices that can be connected between an infusion setup and a sampling or infusion device like a syringe. By separating the internal and external casings of the fluid flow control device, a fluid flow path is established, allowing for precise control of fluids during medical procedures.

Career Highlights:

With an impressive total of 162 patents to his name, Laufer's career highlights his dedication and commitment to improving medical practices. His innovative mind has led to the development of cutting-edge medical technologies aimed at enhancing patient care and treatment outcomes. Laufer's contributions have positioned him as a leading figure in the medical device sector.

Collaborations:

Throughout his career, Michael D Laufer has collaborated with renowned professionals in the industry, bringing together expertise and knowledge to push the boundaries of medical innovation. Among his notable collaborators are Christopher James Danek and Bryan Loomas, both esteemed individuals known for their contributions to the field. These collaborations have helped foster an environment conducive to groundbreaking inventions and patents.

Conclusion:

Michael D Laufer's impact on medical device innovation cannot be overstated. Through his extensive patent portfolio and inventive mindset, Laufer has consistently shown his commitment to advancing healthcare practices. His focus on fluid control devices and resuscitation methods demonstrates his dedication to improving patient outcomes and pushing the boundaries of medical technology. With his impressive career achievements, Laufer continues to inspire and shape the future of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…